Dr. Kris Discusses the Field of Mutation Testing

Mark G. Kris, MD
Published: Tuesday, Jul 26, 2011

Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, discusses how the field of mutation testing is changing rapidly as tests become more available and easier to complete. As the quality of the genetics tests increase the price is also decreasing making their use more widely available.
Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, discusses how the field of mutation testing is changing rapidly as tests become more available and easier to complete. As the quality of the genetics tests increase the price is also decreasing making their use more widely available.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Novel Therapeutic Options for Lung Neuroendocrine TumorsMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x